ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1996;62:212
© 1996 The Society of Thoracic Surgeons

Discussion

Discussion

The first 20% of the full text of this article appears below.

See also page 207.

DR NEIL K. WORRALL (St. Louis, MO): Mattsson and associates are to be congratulated on a well-designed study that confirms and extends our own previously reported findings with Drs Bruce Ferguson and Alec Patterson on the efficacy of aminoguanidine in the treatment of acute lung and cardiac allograft rejection.

I have several questions for Dr Mattsson. First, do you have any thoughts as to why the allograft serum nitrite levels were significantly elevated before you had iNOS messenger RNA present in the allografts and why the serum nitrite levels returned to normal on day 6 when there . . . [Full Text of this Article]


Related Article

Effect of Aminoguanidine and Cyclosporine on Lung Allograft Rejection
Pella Mattsson, Adriana Zeevi, Jane Cai, Samuel A. Yousem, Rosemary Hoffman, Michael Nalesnik, Gilbert J. Burckart, David Geller, and Bartley P. Griffith
Ann. Thorac. Surg. 1996 62: 207-212. [Abstract] [Full Text]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.